Panchakarma rationale
How much weight this concept bears. The classical rationale is well attested and, after this revision, cited at the level of the operative procedures rather than only at the level of the principle. The sequencing detail is specific enough to be checkable: three days of oily food after oleation before purgation and one before emesis (Ca.Su.13.80-81), seven days between a purgative and the oil enema and the oil enema before the decoction enema (Bhishagratna's Chikitsa XXXVII.2 and XXXVIII.1), a purgative dose set by the threefold koshtha (XXXIII.15), and a gruel count set by the measured volume expelled (XXXIX.3-4). It is not internally consistent, and this revision withdraws the claim that it is. Three inconsistencies sit inside the record's own sources. The membership of the five cannot be settled from them: the one passage in the retrieved material that enumerates a group of five names oleation, purgation, emesis, asthapana and anuvasana, which matches neither scheme the record previously contrasted, and it does so in the translator's gloss rather than in the text. Charaka Sutrasthana 16 counts increase of the digestive fire among the signs of a properly purified body while Sushruta's recovery chapter opens by saying the digestive fire grows dull after exactly these procedures, a tension Bhishagratna resolves in a footnote of his own. And Bhishagratna records Dallana reading the word 'panchakarma' in Sushruta Chikitsa 13 as something else entirely. On top of that, the two stated payoffs, durability and preparation for rasayana, are both argued by analogy: faults subdued by correctives cannot reappear (asserted), a purged body is a tank baled dry, an unprepared body is sapless wood, an uncleansed body is dirty cloth. The one passage that offers something closer to a mechanism, XXXIII.21-22, explains the two routes by whether the drug is digested, which is a claim about the drug and not about the dosha. The modern evidence does not test the central claims, on the evidence this record searched, and the searches are now named in gatheringNotes rather than left implicit. No systematic search was run and none is claimed. Within those searches: the strongest study, Peterson et al. 2016, is a real controlled metabolomic study with proper multiple-testing correction, but the intervention it tested was a six-day residential programme combining herbs, vegetarian diet, meditation, yoga and massage, so its finding of altered plasma phosphatidylcholines cannot be attributed to the eliminative procedures, and the paper makes no clinical outcome claim. The clinical trials that do isolate a procedure are small, unblinded, lack a no-procedure arm, and confound the procedure with a follow-on palliative drug. The most obvious modern mechanistic hypothesis, that these are gut-directed interventions acting through the microbiome, is described in a 2024 review as nascent with too few studies to support categorical conclusions. A 2026 registered protocol from an Ayurvedic university is still single-arm with surrogate endpoints, which is itself a fair index of where the field stands. On safety, this revision stops asserting that nothing was found. The search found one prospective single-centre pharmacovigilance survey that attributes 23 of 52 confirmed adverse drug reactions in a hospital year to panchakarma, with no per-procedure denominator, and one 15-patient before-and-after study of serum electrolytes after purgation. Neither gives an adverse-event rate. A 2008 JAMA assay of internet-sold Ayurvedic medicines, which found detectable lead, mercury or arsenic in a fifth of 193 products, is recorded as context for the safety of orally administered classical preparations and explicitly not as evidence about the drugs used in panchakarma, which it did not sample. The honest summary is that panchakarma is a well-documented and elaborately specified traditional procedure, specified down to the dose and the meal count, whose central claims of durability and preparation for rasayana have not been tested in anything this record located, whose one respectable piece of biochemical data does not bear on those claims, and whose own textual tradition does not agree on what the five procedures are.
Panchakarma is the name used for a set of five eliminative procedures that constitute internal shodhana, together with the preparatory and recovery phases that surround them. The stated rationale is sequential and mechanical: aggravated doshas that have lodged in the tissues must first be loosened and brought back to the gut by internal and external oleation (snehana) and heat (swedana), then expelled by the route appropriate to the dosha and its seat, then followed by a graded re-feeding regimen (samsarjana krama) while digestive capacity is weak. Each of those three steps is now cited to an operative passage: Sushruta's emesis-and-purgation chapter states the loosening step and makes it mandatory, distinguishes the upward from the downward route by the behaviour of the drug, and grades the dose to the bowel type; Sushruta's post-procedure chapter and Charaka's Sutrasthana 15 give the graded re-feeding. The claimed payoff is durability, since Charaka holds that faults subdued by correctives cannot reappear and Sushruta compares a purged body to a tank baled dry, and preparedness, since Sushruta holds that rejuvenative therapy given to an uncleansed body is like dyeing a dirty cloth. Both payoffs are argued by analogy rather than by a mechanism. What the five procedures are is not settled and this record does not settle it: the enumerations it can actually source do not agree with each other, and in Sushruta a commentator is recorded disputing the ordinary reading of the word. The record cites procedural passages for emesis, purgation, both enemas, nasal administration and the graded re-feeding. It cites none for bloodletting and quotes no Vagbhata at all; both limits are stated in notKnown rather than left silent.
| Subject area | Principles of treatment |
|---|---|
| Domain, as recorded | treatment-principles |
| Contested questions | 6 |
| Stated as not known | 12 |
| Classical citations | 21, 20 quoting the text |
| Research papers assessed | 9 |
| Citations checked | 2026-10-08 |
What is contested, and by whom
These are the questions on which the sources genuinely disagree. Each position is given as its source states it. No position is presented as the settled answer, because none of them is.
What are the five karmas?
This is contested.
- Charaka's set is usually given as vamana, virechana, niruha (decoction) basti, anuvasana (oil) basti and shirovirechana/nasya, with the two enemas counted separately and bloodletting excluded. UNSOURCED IN THIS RECORD: the Charaka passage that enumerates them is in Siddhisthana, which is not in the Kaviratna volume this record reads, and Ca.Su.2.34-35 names 'the five acts' without listing them. The position is retained as the standard report, not as a sourced claim.
- Sushruta and Vagbhata are usually said to count raktamokshana (bloodletting) among the five and to treat the enemas as one. UNSOURCED IN THIS RECORD: no passage in Bhishagratna Volume II that was read enumerates such a set, and no Vagbhata is quoted anywhere in this record. The gathering pass supported this position with a verse attribution for Ashtanga Hridaya Sutrasthana 14 taken from an unnamed chapter summary; that attribution has been removed as unverifiable. The position is retained as the standard report and is flagged so that nothing downstream treats it as cited.
- A third enumeration is actually retrievable, and it matches neither. At Sushruta Sarira Sthana, Bhishagratna's chapter II, sections 5-12, the group named is oleation (sneha-karma), purgatives, emetics, asthapana and anuvasana, and in the next paragraph Bhishagratna glosses the Sanskrit 'oil etc., purgatives etc.' as '(Pancha-karma)', with a footnote supplying those members. Oleation is inside the five here and nasal administration is not. This is the translator reading the term, not Sushruta enumerating it, and it is recorded as such.
- Bhishagratna's footnote to Sushruta Chikitsa 13, section 7 records that Dallana, the standard Sushruta commentator, glosses the term in that passage as something other than the five eliminative measures, taking it to mean the measures used against kushtha affecting bone as the fifth dhatu. The word was not univocal even in the commentarial period.
- The consequence, which this record states rather than resolves: the referent of 'panchakarma' is not stable across the sources this record can quote, and a record that picked one would be choosing rather than reporting.
Do the preparatory steps have an independent rationale or are they part of the eliminative act?
This is contested.
- The classical sequencing rules treat snehana and swedana as mandatory precursors with specified intervals (Ca.Su.13.80-81), and Sushruta states the mobilising function outright: oleation, heat and secretion-producing food so that the doshas 'would be loosened and dislodged from their seats' (Bhishagratna's Chikitsa XXXIII.3).
- The reason Sushruta gives for the preparation being mandatory is an analogy, not a mechanism: a body given a purgative or emetic without prior oleation and heat 'breaks up like a piece of sapless wood at the time of bending it' (XXXIII.33). The same chapter also makes the preparation repeatable and conditional, requiring a second oleation and heat before purgation after an emesis (XXXIII.14) and a drying phase first in those habituated to oily food (XXXIII.29-30), which reads as an independently managed step rather than a formality.
- No study located by the searches named in gatheringNotes separates the preparatory phase from the eliminative phase, so whether snehana and swedana contribute anything beyond the diet and rest they entail is untested here.
- Bhishagratna's own note on Sushruta Chikitsa 32 warns that 'sveda' does not necessarily mean producing sweat, which undercuts readings of the step as a diaphoretic or detoxifying measure in the modern sense. The warning is the translator's, about his own English, and is used here only as that.
Does purification kindle the digestive fire or dull it?
This is contested.
- Charaka Sutrasthana 16, at Kaviratna's aphorisms 14 to 16, lists 'the increase of the digestive fire' first among the signs of one whose system has been properly purified, and makes improved digestive capacity one of the blessings of proper purgation; Sushruta says the same at Bhishagratna's Chikitsa XXXIII.18.
- Sushruta's recovery chapter opens by stating the reverse: 'The digestive fire (Kayagni) of a person naturally grows dull after the exhibition of emetics and purgatives, after the administration of a Niruha-Vasti, after the internal application of a Sneha and after blood-letting' (Bhishagratna's Chikitsa XXXIX.2). The whole graded diet is built on that premise.
- Bhishagratna harmonises the two in a footnote at that point, saying the fire is ultimately kindled by these measures but immediately afterwards becomes dull and sluggish. ATTRIBUTION: that resolution is the translator's. Neither passage as retrieved says it. It is recorded here because it is a plausible reading and because this project has three times absorbed a translator's harmonisation as doctrine, so the attribution is the point.
- What follows for the record: the two statements are both in the sources and the reconciliation is not, so the claim that the classical account is internally consistent has been withdrawn from evidenceState.
Is panchakarma a treatment, a preparatory measure, or a seasonal health practice?
This is contested.
- Charaka Su.16 frames it as definitive treatment with durable effect, and Sushruta's benefits-of-purgation passage (Bhishagratna's Chikitsa XXXIII.18) does the same with a different analogy.
- Sushruta Chikitsa 27.2 frames it as a precondition for rasayana to work, and Bhishagratna's Chikitsa XXXVII.2 frames the oil enema as requiring prior purification in the same way, so the preparatory framing is internal to the procedure set and not only a bridge to rasayana.
- Contemporary practice and the 2026 protocol frame seasonal purification (ritu shodhana) in healthy people as a healthspan measure, a use for which the protocol itself concedes the evidence remains a gray area.
What does the Peterson 2016 metabolomic finding show?
This is contested.
- It is widely cited as biochemical evidence that panchakarma produces measurable physiological change.
- The intervention was a multi-component residential programme, so the same data are equally consistent with six days of vegetarian diet, meditation and rest producing the phosphatidylcholine shift with no contribution from the eliminative procedures. The paper does not claim otherwise.
What can be said about the safety of panchakarma?
This is contested.
- The classical texts describe the harms of over-administration in clinical detail and make them the operator's responsibility: Charaka Su.16 (Kaviratna 7-9) describes graded over-purgation up to dark-blue blood and then tells the patient to seek a learned physician, and Sushruta states flatly that 'purgatives administered by ignorant physicians to persons who ought not to be purged (often) prove fatal' (Bhishagratna's Chikitsa XXXIII.19).
- The modern safety literature the search named is thin but not empty. A prospective single-centre pharmacovigilance survey (PMID 27011712) attributes 23 of 52 confirmed hospital ADRs in one year to panchakarma, mostly mild to moderate and mostly gastrointestinal or cutaneous, with an overall ADR incidence of 1.14 percent in the hospital's patient population. A 15-patient study of serum electrolytes after purgation (PMID 24696575) found deviations within the normal range.
- Neither of those is an adverse-event rate for the procedure. The pharmacovigilance denominator is the hospital population rather than the people who underwent a procedure; spontaneous reporting under-counts; and 23 of 52 is a share of reactions, not a risk. The record states this as an open gap rather than letting the two studies stand in for one.
- A separate and distinct safety question is the composition of the preparations administered. A 2008 JAMA assay (PMID 18728265) found detectable lead, mercury or arsenic in 20.7 percent of 193 internet-purchased Ayurvedic medicines, with no difference by country of manufacture and no protection from a GMP claim. It sampled none of the drugs used in panchakarma, so it bears on the class of product and not on this procedure, and the gap it leaves is recorded in notKnown.
What is not known
Stated rather than left out. Where a negative has actually been searched for rather than assumed, the entry says so.
- Whether the eliminative procedures contribute anything beyond the diet, rest and practitioner contact that accompany them. No study located by the searches named in gatheringNotes has a component-controlled design.
- Whether effects of panchakarma persist. No study located by those searches includes a follow-up period adequate to test the durability claim at Ch.Su.16.20 or its Sushruta counterpart at Bhishagratna's Chikitsa XXXIII.18.
- What, if anything, is eliminated. No study located by those searches characterises the material removed by vamana or virechana, or shows that its removal relates to any measured outcome. Sushruta measures the quantity expelled in volumetric units (prastha, adhaka) and grades the recovery diet by it (Chikitsa XXXIX.3-4), so the tradition treats the quantity as meaningful; nothing retrieved here identifies what it consists of.
- Whether snehana and swedana are necessary. The waiting intervals in Ch.Su.13.80-81 and the seven-day interval at Bhishagratna's Chikitsa XXXVII.2 are precise enough to test and no test of them was located.
- The adverse-event rate of panchakarma under ordinary practice conditions. The classical texts describe over-administration harms in detail and name misapplication as sometimes fatal. The modern searches named in gatheringNotes found one prospective hospital pharmacovigilance survey (PMID 27011712) and one 15-patient electrolyte study (PMID 24696575), neither of which yields a rate per procedure: the pharmacovigilance denominator is the hospital's whole patient population, and spontaneous reporting under-counts. This record makes no claim about whether a prospective safety cohort exists. The register where Indian Ayurvedic trials are registered, CTRI, was not searched: it was reached today but its search interface returned no results to the queries attempted, so no CTRI search can be reported and no conclusion drawn from its absence.
- Whether the single CTRI registration this record names, CTRI/2024/02/062176, says what the JMIR protocol paper says it says. The number is quoted from that paper's abstract and has not been checked against the register.
- How much procedural variation exists between practitioners and centres for the same named karma, and whether outcomes differ accordingly. Sushruta's own chapters show the scope for it: the dose varies with koshtha, the retention time is given in matras with commentators disagreeing on how many (Bhishagratna's Chikitsa XXXVIII cites Agnivesha and Parashara against each other), and Dallana is repeatedly cited for variant readings.
- Whether the classical eligibility criteria identify anything that predicts response or harm. The criteria are now cited rather than merely named: the threefold koshtha and its dosing rule at Bhishagratna's Chikitsa XXXIII.15, and the exclusion lists at XXXIII.11 and XXXIII.19. The 2026 protocol uses madhyama koshtha, vamanarha and virechanarha as inclusion criteria. No study located here tests whether any of them predicts anything.
- Whether the drugs actually administered during panchakarma carry the heavy-metal contamination found in Ayurvedic products on open sale. PMID 18728265 assayed internet-purchased oral products in 2005 and found detectable lead, mercury or arsenic in 20.7 percent of them, concentrated in rasa shastra preparations; it sampled no emetic, purgative, enema or nasal preparation as dispensed in a panchakarma unit, and no study that does so was located. This record therefore has no basis for a statement either way about the drugs its subject uses.
- SCOPE LIMIT, bloodletting. This record cites no procedural passage for raktamokshana and no passage enumerating it among the five. Sushruta's operative material on bloodletting and leeches sits in Sutrasthana, which is in Bhishagratna's Volume I and was not consulted. Nothing in this record should be read as a claim about raktamokshana beyond its appearance in a list of procedures after which digestion is dull (Bhishagratna's Chikitsa XXXIX.2).
- SCOPE LIMIT, Vagbhata. This record quotes no Ashtanga Hridaya. The project can publish quotations only from Kaviratna's Charaka and Bhishagratna's Sushruta, the two public-domain English translations it has settled on; no public-domain English Ashtanga Hridaya was found, and quoting an in-copyright translation or paraphrasing one as though it were a citation are both barred. The chapter-level address is retained and marked unsourced. Nothing here is evidence about Vagbhata's scheme, including the usual report that he counts bloodletting among the five.
- SCOPE LIMIT, numbering. No standard-edition crosswalk was established for any of the Sushruta citations in this record. Bhishagratna prints no Sanskrit verse numbers, only his own section numbers, and his chapter order for the two enemas (XXXVII anuvasana, XXXVIII niruha) was not checked against a standard edition's. The Sushruta locations here are therefore reproducible in his printing and nowhere else until that crosswalk is done. For Charaka, both numbering systems are now recorded on every entry, and the drift is not uniform: Kaviratna runs two behind in Sutrasthana 2, two behind at Sutrasthana 15.16 while matching exactly at 15.6 and 15.7, and three behind at Sutrasthana 16.20.
The terms this concept is built from
Each is a technical term in its own right. Where this site holds a lexicon entry for one, it is linked.
| Term | What it names |
|---|---|
| Purvakarma: snehana | Preparatory oleation, internal (graded doses of medicated ghee over days) and external, held to loosen dosha from the tissues. Sushruta's operative chapter (Bhishagratna's Chikitsa XXXIII, sections 3 and 33) states the loosening claim and makes the step mandatory before either emesis or purgation. |
| Purvakarma: swedana | Preparatory sudation or heat application, divided by Sushruta into direct heat, vapour, poultice and heated fluid, held to liquefy and mobilise the loosened dosha. Bhishagratna's own note warns that 'sveda' means the application of heat whether or not sweating follows. |
| Vamana | Therapeutic emesis; the upward (urdhva) route, principally directed at kapha. Operative passage: Bhishagratna's Sushruta Chikitsa XXXIII, sections 3-13, with the route difference explained at sections 21-22 by the emetic being undigested and so forcing its way up. |
| Virechana | Therapeutic purgation; the downward route, principally directed at pitta. Operative passage: Bhishagratna's Sushruta Chikitsa XXXIII, sections 14-20, including the threefold koshtha assessment that sets the dose. |
| Niruha / asthapana basti | Decoction enema. Operative passage: Bhishagratna's Sushruta Chikitsa XXXVIII, which places it after the oil enema and requires oleation and sudation first. Charaka's scheme is usually said to make this the principal measure against vata; this record cites no Charaka passage for that and does not assert it. |
| Anuvasana basti | Oil enema, treated as a procedure distinct from the decoction enema. Operative passage: Bhishagratna's Sushruta Chikitsa XXXVII, section 2, which sets it seven days after a purgative and forbids it in a body not already cleansed. |
| Nasya / shirovirechana | Nasal administration, treated as cleansing of the head and neck region. Operative passage: Bhishagratna's Sushruta Chikitsa XL, section 18, which divides nasya into shiro-virechana and snehana and then into five named forms. |
| Raktamokshana | Bloodletting. Routinely listed among the five in later and in modern accounts. This record cites no classical passage that enumerates it among the five and no procedural passage for it: Sushruta's operative material on bloodletting sits in Sutrasthana, which is in Bhishagratna's Volume I and was not consulted here. See notKnown and contested. |
| Paschatkarma: samsarjana krama | The graded post-procedure diet, from thin gruel upward, held to rebuild digestive capacity; treated as part of the procedure, not an afterthought. Operative passages: Charaka Sutrasthana 15 (Kaviratna's aphorism 18, standard 15.16), which gives a twelve-meal progression, and Bhishagratna's Sushruta Chikitsa XXXIX, sections 2-4, which proportions the diet to the quantity eliminated. |
The classical passages
Each citation gives its address so a reader can check it in a printed edition, our account of what it establishes, and the result of reading it against its source.
Charaka SamhitaSutrasthana 2 (Apamarga Tanduliya):standard 2.34-2.35; Kaviratna prints 32 and 33 after the two aphorisms · checked against the source
Thus have been mentioned the eight and twenty varieties of Gruel. The drugs, in brief, have also been spoken of, that are used in the five acts, (viz., purgation, vomiting, &c.). Those drugs that were spoken of before for imparting a knowledge of roots and fruits have been mentioned again for imparting a knowledge of how they are used in connection with the five acts.
That the group of five (pancha karma) is treated as an organising category for materia medica this early in the Sutrasthana, and that the same drugs are deliberately re-presented from the standpoint of the five procedures. It does not enumerate the five: Kaviratna's text names purgation and vomiting and then abbreviates.
Charaka SamhitaSutrasthana 13 (Snehadhyaya):standard 13.80-13.81; Kaviratna prints 76 after the first aphorism and leaves the second unnumbered, the next number in his sequence being 77 · checked against the source
One who, after having taken Oils, wishes to take a purgative, should wait for three days, eating during that period food that is oily, liquid, and warm, and that is mixed with the juice of meat. One who, after having taken Oils, wishes to take an emetic, should wait for one day after having eaten the same kind of food ( as is mentioned in the last Verse ) during that day.
The sequencing rule that makes panchakarma a staged procedure rather than a single act, including a specific and differential waiting interval between oleation and the two main eliminative routes.
Charaka SamhitaSutrasthana 16 (Chikitsaprabhritiya):standard 16.20; Kaviratna prints 17 after the aphorism · checked against the source
The faults of the system, if subjugated by fasts and Pachanas, may reappear. If subjugated by correctives, they cannot reappear.
The durability claim that is the primary justification offered for undertaking panchakarma rather than a drug regimen. It is asserted, not argued.
Charaka SamhitaSutrasthana 16 (Chikitsaprabhritiya):standard 16.9-16.10 and 16.12; Kaviratna prints 7 after the first part of the quote and 9 after the second, with his 8 falling inside the ellipsis · checked against the source
The indications of an excessive or over administration of purgatives are evacuation, in the first instance, of stools, bile, phlegm, and wind in due order, and then the discharge of blood that looks like liquified fat or broth of meat, and after this, the discharge of pure water without any phlegm or bile being mixed with it, and then blood of a dark blue. The other symptoms are thirst and pain in consequence of the obstruction of wind. ... Hence, in the matter of the administration of purgatives and emetics for purifying or correcting the constitution of its faults, an intelligent man should seek a learned and skilful physician for his help, one, that is, who will bestow upon him both long life and happiness.
That the classical tradition itself treats these procedures as carrying real and describable harm when over-administered, and conditions their use on operator skill. Relevant to any modern safety assessment.
Charaka SamhitaSutrasthana 15 (Upakalpaniya):standard 15.16; Kaviratna prints 18 after the aphorism · checked against the source
The patient should then, in the evening of that day, or on the next day, be caused to bathe in lukewarm water. Take then a little quantity of red Cali rice, boil it in water and make a manda of it. The Liquid portion that is to be obtained after the manda has settled down is the gruel that should be administered, while still agreeably warm, to the patient. Marking the strength of his appetite, similar food should be administered to him when the time comes for his second as also his third act of eating. ... After that, the same kind of diet should be continued for a week in succession. On the expiry of a week, however, the patient may betake himself to his usual regimen.
The samsarjana krama itself, which this record previously named as a component and cited nowhere. Charaka specifies a twelve-meal progression after emesis: thin rice gruel (manda) for meals one to three, a thicker jelly-like preparation for four to six, soft rice with mudga soup for seven to nine, rice with meat decoction for ten to twelve, then the same diet for a week before the ordinary regimen resumes. The graded diet is given as a numbered procedure, not as general advice.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 32 (Sveda-vacharaniya), Bhishagratna's chapter XXXII:Bhishagratna's section 2 · checked against the source
Sveda (calorification, fomentation, diaphoretic measures, etc.) may be divided into four groups such as, the application of direct heat (Tapa-sveda), fomentation (Ushma-sveda), poulticing (Upanaha sveda) and the application of heated fluids (Drava-sveda). All kinds of diaphoretic measures (Sveda) belong to one or the other of these groups.
The classification of the preparatory heat phase into four kinds.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 13 (Madhu-Meha), Bhishagratna's chapter XIII:translator's footnote attached to Bhishagratna's section 7 · checked against the source
Some take the term in its ordinary sense to mean the five measures of emetics, purgatives, etc. ; but Dallana would explain it as the measures adopted in the treatment of the Kushtha affecting the bone which is the fifth Dhatu in the system.
That the referent of the word 'panchakarma' is disputed inside the classical commentarial tradition. Dallana, the standard commentator on Sushruta, is reported here as reading it in this passage as something other than the five eliminative procedures. This is evidence that the word was not univocal, and it is deliberately recorded as a translator's footnote reporting a commentator, not as a statement of the text.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 27 (Sarvopaghata-shamaniya Rasayana), Bhishagratna's chapter XXVII:Bhishagratna's section 2 · checked against the source
A person whose system has not been (previously) cleansed (Sodhana) with the proper purifying remedies (emetics and purgatives) should not, in any case, have recourse to such tonics inasmuch as they would fail to produce the wished-for result, just as the application of a dye to a piece of dirty cloth will prove non-effective.
The second major rationale for panchakarma beyond direct treatment: it is held to be a precondition for rasayana to work at all. The justification offered is an analogy (dye on dirty cloth), not a mechanism.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 33 (Vamana-Virechana-Sadhyopadrava), Bhishagratna's chapter XXXIII:Bhishagratna's sections 2 and 3 · checked against the source
The principal maxims to be followed are to augment the loss or deficiency, to pacify the aggravation and reduce the increment of the Doshas and maintain them in a state of healthy equilibrium. Emetics and purgatives are the principal remedies in cleansing the system of all the Doshas (morbific principles). Now hear me, therefore, discourse on the mode of their administration. The body of the patient should be first anointed with a Sneha (oil, etc.) and Sveda should then be applied thereto. He should then be made to partake of meals which would produce internal secretions from the system, so that all the Doshas (morbific diathesis, etc.) accumulated in the organism would be loosened and dislodged from their seats.
The core mechanical rationale, in the operative chapter rather than inferred from the preparatory ones: oleation, then heat, then secretion-producing food, for the stated purpose of loosening and dislodging dosha from its seat before it is expelled. This is the passage the record's summary was describing and had never cited.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 33 (Vamana-Virechana-Sadhyopadrava), Bhishagratna's chapter XXXIII:Bhishagratna's section 15 · checked against the source
Koshtha (bowels) may be grouped under three heads as mild or easily movable (Mridu), middling or moderately constipated (Madhya) and hard or constipated (Krura). The first kind (Mridu) of the Koshtha should be ascribed to the abundance of Pitta therein and can be moved even with milk only ; the last (Krura) is ascribable to the action of an abundance of Vayu and Kapha and can be moved only with the greatest difficulty ; while the second, Madhayama, should be held as the product of a condition of equilibrium among the (three) Doshas and this is the most general type. Purgatives should be administered in small doses to persons of lax bowels (Mridu Koshtha), in moderate doses to those of moderately constipated bowels (Madhayama Koshtha), and in large doses to persons of extremely constipated bowels (Krura Koshtha).
The classical eligibility and dosing assessment that the record's notKnown names (koshtha assessment) and had never cited. The threefold koshtha is not a descriptive aside: it sets the purgative dose. The same category appears as an inclusion criterion in the 2026 registered protocol recorded under modern, which requires madhyama koshtha.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 33 (Vamana-Virechana-Sadhyopadrava), Bhishagratna's chapter XXXIII:Bhishagratna's section numbered 18 (see verificationNote: his numbering around this point is printed 18-A, 18-B and 18) · checked against the source
Clearness and expansion (Prasada) of the intellect, firmness of the organs and of the Dhatus (root-principles) of the body, increase of energy (Bala), improved digestive capacity and a late or delayed old age are the blessings which follow a proper administration of purgative remedies. The deranged Pitta of the system, having been fully removed (with the help of a purgative), precludes the possibility of the existence of any Pitta-origined complaint, just as the waters of a tank or any other reservoir of water, having been fully baled out, bar against the possibility of the existence of all aquatic animals and plants living therein.
Sushruta's version of the durability claim, parallel to Charaka Sutrasthana 16 but argued by a different analogy: the purged body is a drained tank in which nothing can live. The emesis counterpart in the same chapter at Bhishagratna's 9-10 uses a felled tree drying up with its twigs and fruit. Both are analogies offered in place of a mechanism, which is the point this record needs them for.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 33 (Vamana-Virechana-Sadhyopadrava), Bhishagratna's chapter XXXIII:Bhishagratna's section 19 · checked against the source
Exhibition of purgatives are prohibited in respect of persons of impaired digestion, or of those treated with an excessive application of any emulsive remedy (Sneha-Karma), or of those who are exceedingly corpulent, too old, fatigued, thirsty or intoxicated, or of those suffering from any ulcer. ... A purgative medicine should not be administered before the digestion of a meal previously taken, neither in the diseases due to an abuse of wine, nor in acute catarrh and acute fever or to a newly parturient woman and persons not previously treated with a Sneha (oil or Ghrita). A mild purgative may, however, be administered (in cases of emergency) to a person of extremely Pitta-predominant temperament. Purgatives administered by ignorant physicians to persons who ought not to be purged (often) prove fatal.
The exclusion criteria for purgation and the explicit statement that misapplied purgation kills. Together with Charaka Sutrasthana 16 this gives the classical side of the safety question a procedural address, and it establishes that the texts make eligibility, not just technique, the operator's responsibility. The parallel exclusions for emesis stand in the same chapter at Bhishagratna's 11.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 33 (Vamana-Virechana-Sadhyopadrava), Bhishagratna's chapter XXXIII:Bhishagratna's sections 21-22 · checked against the source
Emetic and purgative remedies, in spite of their possessing in common the powers of motion (Saratva), subtlety, keenness, expansiveness and heat-making properties, tend to remove the injurious and deranged morbific principles (Doshas) of the body in (two) different ways by virtue of their respective inherent qualities (Prakriti). A purgative, in the course of its digestion, carries down with it all the Doshas from the system (loosened and dislodged by virtue of its own specific properties). An emetic, on the other hand, is not digested, owing to (its lightness due to) its inherent extraordinary qualities, but it soon forces its way up with the Doshas (to be) removed.
The reason the tradition gives for there being two routes rather than one: the two classes of drug share their active properties and differ only in whether they are digested, so the direction of expulsion follows from the drug's own behaviour. This is the nearest thing in the retrieved classical material to a stated mechanism rather than an analogy, and it is a mechanism about the drug, not about the dosha.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana 33 (Vamana-Virechana-Sadhyopadrava), Bhishagratna's chapter XXXIII:Bhishagratna's section 33 · checked against the source
The body (health) of a patient to whom a purgative or emetic medicine is administered without first applying Sneha and Sveda thereto breaks up like a piece of sapless wood at the time of bending it. The aggravated Doshas dislodged from their seats in the organism through the effects of Sneha and Sveda and stirred by emollient food are easily expelled by emetics and purgatives.
That the preparatory phase is not optional in Sushruta's scheme and that the reason given for it is an analogy (sapless wood snapping when bent) rather than a mechanism. This is the passage that makes the record's contested question about whether snehana and swedana have an independent rationale a real question in the text and not only in the modern literature. The same chapter's closing aphorism is the one that states it.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana Bhishagratna's chapter XXXVII (Anuvasana-Uttara-Vasti-Chikitsita):Bhishagratna's section 2 · checked against the source
An Anuvasana-vasti should be applied to a patient fit to be treated therewith, seven days after the administration of a purgative and after he has regained his strength and taken his meal of rice. Three-quarter-parts of the medicinal solution enjoined to be used in connection with a Niruha-vasti (dry or oilless) in consideration of the age and temperament of the patient form the (full) dose of a Sneha vasti. An enema (Vasti) should be applied after the emission of stool, flatus and urine from the system, since they resist the penetration of the Sneha into the bowels. A Sneha-vasti (emulsive or oleaginous enema) should not be applied to a person whose organism has not been previously cleansed (by an appropriate emetic and purgative). The potency of the Sneha would be able to easily infiltrate into a system previously cleansed in the manner before indicated.
The operative passage for the oil enema, and with it a second instance of the staging rule: the enema waits seven days on a purgative, is dosed as three-quarters of the decoction enema, and is barred outright in a body not already purified. The stated reason is absorption, which is a mechanism of a kind, though no evidence is offered for it.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana Bhishagratna's chapter XXXVIII (Nirudhopakrama-Chikitsitam):Bhishagratna's sections 1 and 2-A · checked against the source
Now we shall discourse on the mode of applying as well as on the treatment with a Nirudha-vasti (Nirudhopakrama-Chikitsitam). The application of an Anuvasana-vasti (enema) should be followed by that of one of the Asthapana class. The body of the patient should be first anointed (with a Sneha) and fomented. Previous to the application of a vasti, the bowels and bladder should be relieved of all (foecal) accumulations (flatus and urine). The clyster (Vasti) should be applied at noon in a well-cleansed chamber, devoid of any gust of wind, and the patient should be laid on his left side on a spacious bed not furnished with any pillows, but a little raised up there where his buttocks would rest, and there should be attendants at his feet.
The operative passage for the decoction (niruha / asthapana) enema, and the ordering of the two enemas relative to each other: the oil enema comes first and the decoction enema follows it. It also shows the preparatory pair applying to the enemas and not only to emesis and purgation, which the record previously asserted as a general rule without citing it anywhere.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana Bhishagratna's chapter XXXIX (Aturopadrava-Chikitsitam):Bhishagratna's section 2 · checked against the source
The digestive fire (Kayagni) of a person naturally grows dull after the exhibition of emetics and purgatives, after the administration of a Niruha-Vasti, after the internal application of a Sneha and after blood-letting. It is further lessened by the eating of extremely heavy (difficult of digestion) articles of fare, just as a low or dull fire is extinguished by a heavy load of fuel. Light meals taken in small quantities, on the other hand, increase the digestive fire under these circumstances, just as light fuel in small quantities serves to re-kindle a low fire.
The rationale for the recovery phase, stated in its own chapter: the procedures themselves leave digestion weak, so the diet that follows is part of the procedure. It is also the one retrieved classical passage that lists bloodletting alongside the four other procedures as something after which this applies, which is suggestive about the membership question but does not enumerate a set of five.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana Bhishagratna's chapter XXXIX (Aturopadrava-Chikitsitam):Bhishagratna's sections 3 and 4 · checked against the source
The quantity of diet should be proportionate to the Dosha (morbific diathesis) eliminated from the organism. The quantity of the Dosha or Doshas eliminated consists of three measures, viz., one Prastha, half an Adhaka or an Adhaka (at most). The first is the lowest, the second is the intermediate and the last named measure (one Adhaka) should be deemed as the highest quantity (of the Dosha that can be eliminated under the circumstances). Yavagu (gruel) prepared with a small quantity of rice (Tandula) should be given once, twice or thrice respectively in cases of the eliminated Dosha being a Prastha, half an Adhaka or an Adhaka in quantity.
Sushruta's graded re-feeding, and the rule that grades it: the number of gruel meals is set by the measured volume of what was expelled, after which the diet moves on to vilepi. This is the Sushruta counterpart to Charaka's twelve-meal progression, and it makes the recovery phase quantitative rather than merely cautious.
Sushruta Samhita (Bhishagratna translation, Vol. II)Chikitsa Sthana Bhishagratna's chapter XL (Dhuma-Nasya-Kavala-Graha-Chikitsita):Bhishagratna's section 18 · checked against the source
The term "Nasya" (Snuff) is so called from the fact of its being composed of the powders of any drugs or of any Sneha (oleaginous substance) cooked with such drug or drugs, to be stuffed into the nostrils. It may be broadly divided into two kinds, viz. : Siro-Virechana (errhines) and Snehana (contributor of oleaginous principles) ; and may, however, be further grouped under five specific heads, viz. : Nasya, Siro-Virechana, Pratimarsha (a medicated Sneha poured into the nostrils to be discharged into the mouth), Avapida (the expressed juice of any drug put into the nostrils in drops by pressing it with the palms then and there) and Pradhamana (a medicinal snuff blown into the nostrils with the help of a blow pipe). Of these, the Nasya (snuff) Siro-Virechana (errhines) are pre-eminently the most effective.
The operative passage for nasal administration, which the record listed as a component and cited nowhere. It also supports the component gloss: one of the two broad kinds is explicitly S'iro-Virechana, cleansing of the head, which is why nasya is grouped with the eliminative procedures rather than with local treatment. This section goes no further than naming nasya and classifying it, twofold into S'iro-Virechana and Snehana and fivefold into Nasya, S'iro-Virechana, Pratimarsha, Avapida and Pradhamana; it does not describe how a nasya is given, and no claim about the procedure rests on it. In the same chapter, and read verbatim in the same scan, Bhishagratna's section 19 is the S'iro-Virechana drug list with its Kaphaja indications, his section 20 is the timing of administration, and the procedure, including the preparatory fomentation of neck, cheek and forehead, is at his section 21, not at sections 19-20 as this record previously said.
Sushruta Samhita (Bhishagratna translation, Vol. II)Sarira Sthana Bhishagratna's chapter II (Sukra-shonita-shuddhi):Bhishagratna's sections 5-12, and the sentence he numbers next · checked against the source
In all cases of seminal disorders as well as in menstrual anomalies, Uttara-Vasti (uretheral or vaginal injection) should be made after having recourse to the application of medicated oil etc. (Sneha-karma), purgatives, emetics, Asthapana and Anuvasana measures. ... In all the four cases when the catamenial blood would be found to be vitiated (by the deranged Vayu, Pittam, Kaphah or Sonita), the preliminary remedial measures of the application of oil etc. purgatives etc. (Pancha-karma) should be first employed
A third enumeration, and the reason the membership question cannot be settled from this record's sources. The group of procedures named here is oleation, purgation, emesis, asthapana and anuvasana: five, with oleation counted in and with neither nasal administration nor bloodletting present. That is not Charaka's usually reported set and not the set usually attributed to Sushruta. It must be read with care, because the word 'Pancha-karma' appears here as Bhishagratna's parenthetical gloss on an 'etc.' in the Sanskrit and his footnote supplies the members ('The word "Adi" in the text includes emetics, purgatives, Anuvasanam and Asthapanam measures according to their specific Doshas'). So this entry is evidence that the translator read the word as naming this set; it is not evidence that Sushruta enumerated it.
Ashtanga Hridaya (Vagbhata)Sutrasthana 14 (Dvividhopakramaniya), and 18-20
Chapter-level address only. Ashtanga Hridaya Sutrasthana 14 is the chapter on the two kinds of therapy, and Sutrasthana 18-20 are usually cited as the operative chapters on emesis and purgation, enema and nasal administration. This record makes no claim about what any of those chapters contains. It quotes no Vagbhata, and nothing in this record should be read as evidence about Vagbhata's scheme.
What the research actually shows
Every paper located for this concept, with what it measured and what it does and does not establish. The assessment is ours.
Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI). · Sci Rep · 2016 · PMID 27611967
In 65 healthy adults undergoing a six-day panchakarma-based residential programme versus 54 controls, a set of 12 plasma phosphatidylcholines decreased with adjusted p below 0.01 after Bonferroni correction, with 57 further metabolites differing at 10 percent FDR. The most-cited piece of hard biochemical data associated with panchakarma.
How much it shows. Empirical with a control group and appropriate multiple-testing correction, published in Scientific Reports, and it carries a published corrigendum. But the intervention bundled herbs, a vegetarian diet, meditation, yoga and massage, so nothing in the design attributes the metabolomic shift to the eliminative procedures rather than to six days of diet change and residential routine. The paper reports a difference in metabolite abundance; it does not test any classical claim about dosha elimination, durability, or clinical benefit, and there is no follow-up.
Ayurvedic Therapies to Target the Microbiome: Evidence and Possibilities. · Altern Ther Health Med · 2024 · PMID 38401105
Review of Ayurvedic therapies as microbiome interventions. Concludes that research connecting Ayurvedic interventions and the gut microbiome is at a nascent stage, and that the small number of studies of virechana and basti prevents categorical conclusions about panchakarma's microbiome effects.
How much it shows. Narrative review, not an empirical study and not a systematic review with a protocol. Its value here is entirely as an honest negative statement from within the field about how thin the mechanistic evidence is for the most obvious candidate mechanism.
Evaluation of Vamana and Virechana as Interventions to Decelerate the Aging Process in Healthy Adult Volunteers: Protocol for an Exploratory Single-Arm Clinical Trial. · JMIR Res Protoc · 2026 · PMID 42748372
Registered protocol for an exploratory single-arm study of seasonal vamana and virechana in 53 healthy adults aged 35 to 65, measuring serum malondialdehyde, total superoxide dismutase and telomerase activity. The abstract records the registration as CTRI/2024/02/062176 and states the design 'is exploratory and lacks a control group'. Its inclusion criteria are classical: madhyama koshtha assessed by questionnaire, and vamanarha and virechanarha status.
How much it shows. A protocol with no results, explicitly single-arm with no control group, on surrogate biomarkers. Recorded because it states from inside the field that the rejuvenative effect of seasonal purification in healthy individuals 'remains a gray area', and because a single-arm design in 2026 indicates the state of the evidence base. The CTRI number reaches this record through this paper's abstract and has not been checked against the CTRI register itself; see notKnown.
Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study. · Ayu · 2013 · PMID 24049408
Open randomised comparison of virechana versus basti (both followed by the same palliative preparation) in 33 patients with essential hypertension, reporting greater blood-pressure relief in the virechana arm.
How much it shows. Weak. Small, unblinded, no arm without a panchakarma procedure, both arms confounded by the shared shamana drug, and results given as percentage relief without effect sizes or confidence intervals.
Effectiveness, safety, and standard of service delivery: A patient-based survey at a pancha karma therapy unit in a secondary care Ayurvedic hospital. · J Ayurveda Integr Med · 2011 · PMID 22253510
Patient-based survey of effectiveness, safety and service delivery at a panchakarma unit in a secondary-care Ayurvedic hospital.
How much it shows. Uncontrolled patient survey, subject to selection and courtesy bias, and not a measure of efficacy. Included as one of the few sources that looks at panchakarma as it is actually delivered rather than as an idealised protocol.
Ayurvedic PG education and Panchakarma. · Ayu · 2013 · PMID 24049419
Editorial from a panchakarma department head on the state of postgraduate panchakarma education.
How much it shows. Editorial, no abstract, no data. Recorded only as documentation that concerns about the standardisation of panchakarma training and practice are raised inside the discipline; it should not be cited for any factual claim about procedure or outcome.
Pharmacovigilance study of Ayurvedic medicine in Ayurvedic Teaching Hospital: A prospective survey study. · Ayu · 2015 · PMID 27011712
Prospective one-year adverse-drug-reaction monitoring study at an Ayurvedic secondary-care teaching hospital in Belgaum, by spontaneous and intensive monitoring, June 2010 to May 2011. Of 84 reported adverse drug events, 52 were confirmed as ADRs, an overall incidence of 1.14 percent in the patient population. Of those 52, the abstract attributes 23 (44.23 percent) to panchakarma, 13 (25.00 percent) to herbal formulations and 6 (11.53 percent) to rasa aushadhi. Gastrointestinal (24) and skin (15) were the commonly affected systems; 30 reactions were moderate and 20 mild in severity, and most patients recovered.
How much it shows. This is the closest thing the searches named in gatheringNotes found to an adverse-event rate for panchakarma under ordinary practice conditions, and it is why the record's previous unbounded negative on that point has been withdrawn. It is still not an adverse-event rate for panchakarma: it is a single-centre, single-year pharmacovigilance survey whose denominator is the hospital's whole patient population rather than the people who underwent a procedure, so no per-procedure rate can be read off it. It depends on spontaneous reporting, which under-counts. The 44.23 percent is a share of confirmed ADRs, not a risk. The authors' own framing is that systematic documentation of ADRs in Ayurveda is lacking and that the work is a step toward pharmacovigilance, not a measure of it.
Clinical study to evaluate the effect of Virechanakarma on serum electrolytes. · Ayu · 2013 · PMID 24696575
Before-and-after measurement of serum electrolytes in 15 patients undergoing virechana, undertaken to ask whether therapeutic purgation causes the electrolyte disturbance that diarrhoeal fluid loss would predict. The authors report the deviations as remaining within the normal range and read that as suggesting virechana is safely applied.
How much it shows. Weak, and recorded for what it attempts rather than what it shows. Fifteen patients, single arm, no control, no blinding, a surrogate endpoint, and a conclusion stated as suggestive by the authors themselves. It is included because it is one of the few retrieved studies that measures a specific harm mechanism the procedure would be expected to produce, which is a different and more testable question than overall safety, and because leaving it out would have left the safety gap looking emptier than the search found it.
Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. · JAMA · 2008 · PMID 18728265
Of 193 Ayurvedic medicines bought from 25 internet vendors in August to October 2005 and assayed by x-ray fluorescence, 20.7 percent (95 percent CI 15.2 to 27.1) contained detectable lead, mercury or arsenic. Prevalence did not differ between US-manufactured (21.7 percent) and Indian-manufactured (19.5 percent) products (P = .86). Rasa shastra products, which combine herbs with metals and minerals by design, had a higher prevalence (40.6 versus 17.1 percent, P = .007) and higher median lead (11.5 versus 7.0 microg/g) and mercury (20,800 versus 34.5 microg/g) concentrations. All metal-containing products exceeded at least one standard for acceptable daily intake, and 75 percent of them carried Good Manufacturing Practices claims.
How much it shows. A strong study of the thing it studied, in JAMA, with a sampling frame, confidence intervals and a stated assay method. It is cited here with a sharp limit, because the distance between it and this record's subject is the whole of its relevance. It sampled oral products sold to the public over the internet in 2005. It did not sample the emetic, purgative, enema or nasal preparations administered during panchakarma, did not sample medicated ghee, and measured no outcome in any patient. It therefore cannot be read as an adverse-event rate for panchakarma, and it does not tell this record anything about the contamination status of the specific drugs panchakarma uses. What it does establish is that contaminant content in Ayurvedic medicines on open sale was substantial and was not predicted by country of manufacture or by a GMP claim, which is the context any safety discussion of orally administered classical preparations has to sit in. The record carries a notKnown entry for the gap it leaves open. It also carries a published erratum (JAMA 2008 Oct 8;300(14):1652) and a published comment with author reply (JAMA 2009 Jan 21;301(3):271-2), neither of which was retrieved.
How to cite this entry
Age Ayurveda Nighantu, Panchakarma rationale
, https://nighantu.ageayurveda.com/concept/panchakarma-rationale/,
CC BY 4.0. The whole set is downloadable from the concept index.
Machine-readable source: Markdown.
Data exported 2026-10-08.
Educational reference only. This page describes what a body of theory claims and how well it is evidenced. Nothing here is advice, and nothing here describes how any condition should be treated.